Turnover: 700000 EUR (2019)
Country: France
We are an innovative clinical-stage gene therapy company dedicated to the discovery, development and commercialization of innovative therapies for patients with severe neurodegenerative diseases of the retina.
Studies mentioning this company
Other companies mentioned:
- Sanofi Aventis
- Cellectis
- Généthon
- Gensight Biologics
> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)
Sector-GPT est la première IA dédiée aux informations sectorielles.